Published in Blood Weekly, January 27th, 2011
"This has been demonstrated through in vitro studies by flexible photosensitizers, which specifically target nucleic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.